ACQUIREDT+30
Neurocrine Biosciences Inc · NASDAQ
+3,587 sh
Filed 15 Sept 2026SEC Form 4view source
- REDUCEDT+30
Neurocrine Biosciences Inc · NASDAQ
−1,936 sh · $302.4K
Filed 15 Sept 2026SEC Form 4view source - REDUCEDT+30
Neurocrine Biosciences Inc · NASDAQ
−826 sh · $130.1K
Filed 15 Sept 2026SEC Form 4view source